Kinnate Biopharma Inc. Rings The Nasdaq Stock Market Closing Bell

[view original post]

[unable to retrieve full-text content]Kinnate Biopharma Inc. (Nasdaq: KNTE), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers, …